Intrauterine Embryo Development With ANECOVA Device

Phase 3TerminatedNCT00480103

Instituto Valenciano de Infertilidad, IVI VALENCIA

Overview

We aim to compare the morphological and chromosomal features of human embryos cultured In Vitro versus those developed in a new In Vivo culture system with encapsulation in utero as well as implantation and pregnancy rate.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SCREENING

Masking

NONE

Conditions

Healthy

Interventions

in vivo (ANECOVA D-1) or in vitro culture in 25-µl droplets of cleavage medium (Medicult®) under paraffin oilDEVICE

Eligibility

Sex: ALLMin age: 18 YearsMax age: 36 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Women age below 37 * Hormonal serum levels within normal ranges (FSH, LH, E2, PRL, P4, T4, TSH) * Negative serologic screening for HIV, Hep B and C * No uterine or ovarian alterations found by ultrasound * Normal BMI (19 - 29 kg/m2). Exclusion Criteria: * At least 8 stage MII oocytes are not retrieved * Endometriosis or PCO * Severe male factor in the partner

Locations (1)

Instituto Valenciano de Infertilidad Spain

Valencia, Spain

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.